Drug pricing

The drug-pricing problem no one wants to talk about

This content was published on May 4, 2026 Tackling the misuse of patents by some big pharma companies could go a long way to bringing down drug prices.

Full transparency from the FOPH on Covid-19 vaccines

Drug pricing

Swiss court forces Covid vaccine procurement transparency

This content was published on Apr 16, 2026 Court forces Switzerland to release unredacted Covid vaccine contracts from the pandemic.

US towards imposition of 100% duties on certain drugs

Trade policy

US expected to impose 100% tariffs on certain drugs: report

This content was published on Apr 2, 2026 The United States is preparing to impose 100% tariffs on certain drugs of pharma companies that haven't reached an agreement with the White House, the Financial Times reports.

Top-selling drugs discounted to lower premiums

Drug pricing

Switzerland mulls discounts on top-selling drugs to cut health costs

This content was published on Feb 19, 2026 The Swiss government has opened a consultation on limiting the steady rise of healthcare costs by granting discounts on best-selling medicines in the country.

Trump in White House. Pharma leaders behind him.

Drug pricing

The art of the deal: what are Trump’s pharma announcements really worth?

This content was published on Feb 18, 2026 Big Pharma announced a series of groundbreaking agreements with the White House in 2025. But how much of it is just for show?

Novartis: new global biomedical research centre opens in San Diego

Pharma supply chains

Novartis begins construction of new research centre in San Diego, US

This content was published on Feb 9, 2026 Novartis has begun work on a new global biomedical research centre in San Diego, United States. The 43,300 m2 facility will be operational in 2029 and house around 1,000 employees.

Medicines: sales increase by 5% in Switzerland in 2025

Drug pricing

Swiss medicine revenues pegged back by price reductions

This content was published on Feb 7, 2026 Swiss pharma market records CHF8.1 billion revenues at factory prices in 2025.

Drug pricing

Europe races to placate pharma as Trump turns up the pressure

This content was published on Dec 29, 2025 Tariff deals with the US have bought time but investment momentum is elsewhere.

Ethylene: Clariant rejects MOL and Braskem accusations

Drug pricing

Clariant rejects complaints over EU ethylene antitrust case

This content was published on Dec 22, 2025 Chemicals manufacturer Clariant has rejected two complaints for breaches of competition law on the ethylene purchasing market.

Healthcare costs and old-age provision concern the Swiss

Drug pricing

Healthcare costs and financial security in old-age are biggest Swiss worries

This content was published on Dec 9, 2025 Swiss worry most about rising health costs and old-age financial security,

Drug pricing

Popular Stories

Most Discussed

Drug pricing

More

The drug-pricing problem no one wants to talk about

More

Swiss court forces Covid vaccine procurement transparency

More

US expected to impose 100% tariffs on certain drugs: report

More

Switzerland mulls discounts on top-selling drugs to cut health costs

More

The art of the deal: what are Trump’s pharma announcements really worth?

More

Novartis begins construction of new research centre in San Diego, US

More

Swiss medicine revenues pegged back by price reductions

More

Europe races to placate pharma as Trump turns up the pressure

More

Clariant rejects complaints over EU ethylene antitrust case

More

Healthcare costs and financial security in old-age are biggest Swiss worries

Popular Stories

Most Discussed